ArticleFrontiers in psychiatry2025
Associations between blood systemic inflammatory markers and anxiety in
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Chronic Helicobacter pylori (H. pylori) infection is associated with both gastrointestinal symptoms and systemic inflammation, which may contribute to the development of psychiatric disorders, particularly anxiety. Appropriate psychiatric interventions have been shown to significantly enhance treatment outcomes in patients undergoing clinical management for H. pylori infection. Early screening for anxiety in this population is therefore of critical clinical importance. This study aimed to identify potential biomarkers for anxiety detection and evaluate the relationship between these biomarkers and anxiety symptoms in H. pylori-positive individuals. Method: A total of 160 participants (81 H. pylori-positive and 79 H. pylori-negative patients) were enrolled in this study. All participants underwent standardized neuropsychological assessments and venous blood collection. Systemic inflammation indices were derived from routine hematological parameters. Results: (1) H. pylori-positive patients showed significantly higher anxiety scores [Hamilton Anxiety Scale (HAMA) and Self-Rating Anxiety Scale (SAS)] and elevated inflammatory markers [systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI)] as compared to H. pylori-negative ones. (2) AISI showed optimal diagnostic accuracy for infection status [area under the curve (AUC) =0.746)], followed by SIRI and SII (both AUC > 0.7). (3) In H. pylori-positive patients, inflammatory markers correlated with both anxiety scores and glial fibrillary acidic protein (GFAP) levels. (4) Interactions between serum GFAP and blood SII and AISI were significantly associated with HAMA and SAS scores in H. pylori-positive patients. (5) The GFAP as the mediator, affected the relationship between the blood levels of systemic inflammatory markers and HAMA and SAS scores in H. pylori-positive patients. Conclusion: Our findings suggest systemic inflammation indices contribute to anxiety development in H. pylori infection and may serve as practical biomarkers for anxiety screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.